from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2658c/-

LFCtreatmentdescriptionclass of inhibitor

-0.214

Amikacinug/mL Amikacintranslation

0.016

Cap5-10ug/mL Capreomycintranslation

-0.536

Rox10-50 ug/mL Roxithromycintranslation

-0.153

SM2-5 ug/mL Streptomycintranslation

0.434

Tet5-10 ug/mL Tetracyclinetranslation

-0.014

Rif0.2-5ug/mL Rifampicintranscription

-0.245

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.304

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.175

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.230

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.015

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.414

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.630

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.577

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.161

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.103

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.371

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.302

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.164

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.048

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.167

KCN5-20 ug/mL Potassium cyaniderespiration

-0.429

NaN30.2-2 mM Sodium aziderespiration

-0.145

Nigericin50 uM Nigericinrespiration

0.962

TRC10-150 ug/mL Triclosanrespiration

0.636

TRZ10-25 ug/mL Thioridazinerespiration

1.049

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.144

menadione6-10 ug/mL Menadionerespiration

-0.510

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.261

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.394

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.038

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.012

NRP_1Non-replicating persistence stage 1dosRassociated

-0.296

Amp0.2mg/mL AmpicillincellWall

-0.453

Cephalexin20-100 ug/mL CephalexincellWall

0.568

Cerulenin0.32-5 ug/mL CerulenincellWall

0.021

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.202

EMB10-20 ug/mL EthambutolcellWall

-0.033

Eta12-40 ug/mL EthionamidecellWall

0.145

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.133

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.556

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.887

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.734

BZA0.12 mg/mL BenzamidearomaticAmides

-0.350

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.526

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.004

H2O24 mM hydrogen peroxideDNAdamaging

-0.339

Levo10 ug/mL LevofloxacinDNAdamaging

-0.675

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.757

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.056

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.860

UVUV-irradiationDNAdamaging

1.243

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.159

Antimycin12.5-50 ug/mL Antimycin A?

-0.467

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.062

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.288

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.755

PA8240.2-2 ug/mL PA-824?

1.441

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.331

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.349

Verapamil50 uM Verapamil?

-0.350

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.667

methoxatin10-20 ug/mL Methoxatin?